Review
Published on 16 Nov 2022
Intracellular VHHs to monitor and modulate GPCR signaling
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1048601
- 5,330 views
- 6 citations
Type at least 3 characters
761 articles
Articles
Editorial
Published on 16 Nov 2022
Editorial: Emerging receptors as new targets in health and disease
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1073794
- 1,435 views
Review
Published on 15 Nov 2022
Crucial role of T cells in NAFLD-related disease: A review and prospect
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1051076
- 6,444 views
- 16 citations
Review
Published on 11 Nov 2022
A review on phytochemical and pharmacological facets of tropical ethnomedicinal plants as reformed DPP-IV inhibitors to regulate incretin activity
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1027237
- 5,737 views
- 25 citations
Perspective
Published on 07 Nov 2022
Mitochondrial genomic integrity and the nuclear epigenome in health and disease
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1059085
- 3,880 views
- 11 citations
Original Research
Published on 03 Nov 2022
Resveratrol enhances A1 and hinders A2A adenosine receptors signaling in both HeLa and SH-SY5Y cells: Potential mechanism of its antitumoral action
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1007801
- 2,854 views
- 5 citations
Original Research
Published on 02 Nov 2022
Low-normal serum unconjugated bilirubin levels are associated with late but not early carotid atherosclerotic lesions in T2DM subjects
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.948338
- 2,063 views
- 6 citations
Review
Published on 02 Nov 2022
Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1035159
- 4,458 views
- 7 citations
Review
Published on 24 Oct 2022
Bone-kidney axis: A potential therapeutic target for diabetic nephropathy
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.996776
- 4,116 views
- 5 citations
Original Research
Published on 24 Oct 2022
Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.967848
- 3,084 views
- 2 citations
Editorial
Published on 19 Oct 2022
Editorial: Endocrine and metabolic diseases – genetic impact and therapies
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1063167
- 1,414 views
- 2 citations
Mini Review
Published on 19 Oct 2022
Menopause and development of Alzheimer’s disease: Roles of neural glucose metabolism and Wnt signaling
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1021796
- 4,043 views
- 11 citations
Original Research
Published on 18 Oct 2022
Hypoxia-driven metabolic reprogramming of adipocytes fuels cancer cell proliferation
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.989523
- 5,520 views
- 11 citations
Original Research
Published on 14 Oct 2022
Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1011669
- 16,989 views
- 77 citations
Editorial
Published on 14 Oct 2022
Editorial: Novel therapeutic strategy against obesity by targeting thermogenic fat
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1052966
- 1,526 views
- 1 citation
Review
Published on 13 Oct 2022
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway
in Cellular Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2022.1024423
- 6,436 views
- 18 citations